Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
1.590
+0.030 (1.92%)
At close: Aug 13, 2025, 4:00 PM
1.560
-0.030 (-1.89%)
Pre-market: Aug 14, 2025, 8:53 AM EDT
Repare Therapeutics Market Cap
Repare Therapeutics has a market cap or net worth of $68.31 million as of August 14, 2025. Its market cap has decreased by -59.67% in one year.
Market Cap
68.31M
Enterprise Value
-40.52M
1-Year Change
-59.67%
Ranking
Category
Stock Price
$1.59
Market Cap Chart
Since June 19, 2020, Repare Therapeutics's market cap has decreased from $945.76M to $68.31M, a decrease of -92.78%. That is a compound annual growth rate of -39.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 68.31M | 22.65% |
| Dec 31, 2024 | 55.69M | -81.89% |
| Dec 29, 2023 | 307.55M | -50.18% |
| Dec 30, 2022 | 617.25M | -29.87% |
| Dec 31, 2021 | 880.19M | -30.20% |
| Dec 31, 2020 | 1.26B | 33.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 573.84B |
| Johnson & Johnson | 418.81B |
| AbbVie | 348.77B |
| UnitedHealth Group | 229.86B |
| Abbott Laboratories | 229.64B |
| AstraZeneca | 227.85B |
| Novartis AG | 225.61B |
| Novo Nordisk | 222.88B |